Isoflavones & Lignans (so-called Phytoestrogens)
Urinary daidzein
On this Page
Table 5.2.a. Urinary daidzein: Total population
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the total U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 1999–2002. |
|
Geometric mean
(95% conf. interval) |
Selected percentiles (95% conf. interval) |
Sample
size |
|
10th |
50th |
90th |
Males and Females |
Total, 6 years and older |
61.0 |
(55.2-67.3) |
6.75 |
(5.68-8.00) |
59.2 |
(54.0-66.6) |
545 |
(491-642) |
5347 |
6–11 years |
88.1 |
(78.0-99.4) |
15.6 |
(13.0-19.7) |
80.2 |
(68.2-108) |
544 |
(446-726) |
726 |
12–19 years |
89.7 |
(73.2-110) |
10.9 |
(7.50-16.5) |
87.5 |
(74.3-103) |
786 |
(569-1090) |
1497 |
20–39 years |
63.7 |
(55.6-73.1) |
6.59 |
(5.20-8.10) |
57.3 |
(49.9-70.6) |
590 |
(494-781) |
1138 |
40–59 years |
52.3 |
(43.4-63.1) |
5.62 |
(2.90-7.81) |
53.9 |
(44.2-63.0) |
505 |
(397-725) |
951 |
60 years and older |
44.8 |
(38.9-51.6) |
4.80 |
(2.00-6.70) |
44.6 |
(38.7-54.2) |
394 |
(300-519) |
1035 |
Males |
Total, 6 years and older |
64.8 |
(57.2-73.4) |
7.29 |
(5.62-9.40) |
63.0 |
(57.2-70.9) |
542 |
(470-694) |
2595 |
6–11 years |
95.6 |
(77.5-118) |
19.1 |
(14.4-20.3) |
83.6 |
(56.3-139) |
544 |
(443-745) |
368 |
12–19 years |
87.4 |
(65.2-117) |
12.0 |
(6.72-18.7) |
87.5 |
(71.0-118) |
660 |
(445-1100) |
735 |
20–39 years |
64.4 |
(53.6-77.3) |
6.50 |
(4.00-11.4) |
57.0 |
(48.2-69.8) |
663 |
(494-935) |
499 |
40–59 years |
54.8 |
(43.2-69.4) |
5.70 |
(3.50-7.81) |
58.1 |
(49.5-68.4) |
467 |
(332-774) |
480 |
60 years and older |
54.2 |
(44.6-65.9) |
4.89 |
(2.60-8.70) |
57.9 |
(43.3-78.7) |
414 |
(300-576) |
513 |
Females |
Total, 6 years and older |
57.5 |
(51.9-63.7) |
6.41 |
(5.00-8.00) |
56.0 |
(49.3-62.0) |
553 |
(459-702) |
2752 |
6–11 years |
80.7 |
(66.0-98.8) |
13.7 |
(11.3-19.7) |
76.6 |
(62.3-106) |
524 |
(390-989) |
358 |
12–19 years |
92.1 |
(75.4-112) |
10.4 |
(6.10-16.5) |
89.7 |
(70.2-115) |
922 |
(642-1330) |
762 |
20–39 years |
63.1 |
(51.3-77.7) |
7.18 |
(4.70-8.40) |
58.1 |
(48.2-79.2) |
517 |
(411-987) |
639 |
40–59 years |
50.2 |
(40.5-62.1) |
4.40 |
(1.86-8.22) |
46.1 |
(37.8-61.0) |
591 |
(364-1220) |
471 |
60 years and older |
38.7 |
(32.8-45.7) |
4.40 |
(1.80-6.97) |
37.4 |
(32.0-43.6) |
356 |
(280-461) |
522 |
Table 5.2.b. Urinary daidzein: Mexican Americans Geometric mean and selected percentiles of urine concentrations (in µg/L) for Mexican Americans in the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 1999–2002. |
|
Geometric mean
(95% conf. interval) |
Selected percentiles (95% conf. interval) |
Sample
size |
|
10th |
50th |
90th |
Males and Females |
Total, 6 years and older |
55.9 |
(45.6-68.6) |
5.10 |
(2.41-6.76) |
52.5 |
(43.8-67.4) |
618 |
(513-824) |
1495 |
6–11 years |
81.7 |
(56.7-118) |
10.2 |
(4.39-14.0) |
74.5 |
(43.4-123) |
866 |
(534-1240) |
225 |
12–19 years |
71.6 |
(61.0-84.1) |
8.50 |
(6.30-11.4) |
74.6 |
(56.5-98.5) |
595 |
(475-915) |
543 |
20–39 years |
51.9 |
(36.3-74.2) |
3.50 |
(<LOD-6.82) |
47.1 |
(29.7-68.6) |
585 |
(406-931) |
299 |
40–59 years |
46.8 |
(35.3-62.2) |
3.20 |
(<LOD-6.90) |
53.9 |
(35.8-71.4) |
584 |
(297-980) |
221 |
60 years and older |
35.1 |
(24.7-49.8) |
1.96 |
(<LOD-7.99) |
36.3 |
(27.1-47.3) |
366 |
(182-635) |
207 |
Males |
Total, 6 years and older |
62.7 |
(45.6-86.2) |
5.20 |
(1.80-8.41) |
62.9 |
(45.8-85.0) |
745 |
(515-994) |
723 |
6–11 years |
91.4 |
(61.1-137) |
12.7 |
(4.37-26.6) |
84.3 |
(50.0-123) |
896 |
(505-1240) |
117 |
12–19 years |
74.9 |
(57.6-97.4) |
7.50 |
(4.33-11.7) |
81.0 |
(55.8-117) |
664 |
(498-1100) |
276 |
20–39 years |
61.9 |
(37.0-104) |
2.40 |
(<LOD-9.60) |
57.6 |
(30.1-108) |
706 |
(446-1070) |
126 |
40–59 years |
52.5 |
(33.6-82.1) |
5.03† |
(<LOD-11.2) |
56.0 |
(33.5-92.5) |
872† |
(331-1090) |
105 |
60 years and older |
29.1 |
(16.5-51.3) |
< LOD† |
|
31.6 |
(18.2-47.3) |
284† |
(106-659) |
99 |
Females |
Total, 6 years and older |
49.4 |
(41.1-59.4) |
5.40 |
(1.70-7.52) |
45.9 |
(35.7-54.0) |
522 |
(388-682) |
772 |
6–11 years |
72.8 |
(43.9-121) |
6.59† |
(<LOD-12.5) |
60.6 |
(29.5-195) |
824† |
(514-1420) |
108 |
12–19 years |
68.1 |
(57.5-80.8) |
9.70 |
(6.30-11.8) |
69.0 |
(48.5-93.2) |
541 |
(299-1440) |
267 |
20–39 years |
42.2 |
(28.9-61.6) |
4.30 |
(<LOD-10.7) |
35.4 |
(26.3-51.4) |
450 |
(324-669) |
173 |
40–59 years |
41.5 |
(28.4-60.6) |
< LOD |
|
50.1 |
(26.2-71.4) |
302 |
(213-800) |
116 |
60 years and older |
41.0 |
(25.7-65.5) |
2.70† |
(<LOD-11.2) |
37.4 |
(22.8-76.8) |
370† |
(170-804) |
108 |
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD.
† Estimate is subject to greater uncertainty due to small cell size. |
Table 5.2.c. Urinary daidzein: Non-Hispanic blacks
Geometric mean and selected percentiles of urine concentrations (in µg/L) for non-Hispanic blacks in the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 1999–2002. |
|
Geometric mean
(95% conf. interval) |
Selected percentiles (95% conf. interval) |
Sample
size |
|
10th |
50th |
90th |
Males and Females |
Total, 6 years and older |
76.1 |
(62.0-93.4) |
8.10 |
(5.45-11.1) |
88.4 |
(68.8-106) |
628 |
(491-906) |
1288 |
6–11 years |
120 |
(95.7-151) |
12.5 |
(8.61-17.9) |
135 |
(99.1-172) |
1130 |
(628-1850) |
249 |
12–19 years |
119 |
(98.9-144) |
15.1 |
(10.6-20.4) |
118 |
(98.1-148) |
950 |
(660-1370) |
450 |
20–39 years |
77.7 |
(56.4-107) |
9.50 |
(3.00-12.2) |
91.3 |
(58.1-149) |
578 |
(363-1330) |
197 |
40–59 years |
58.7 |
(40.0-86.2) |
6.05 |
(<LOD-12.1) |
66.1 |
(41.5-96.3) |
529 |
(393-816) |
210 |
60 years and older |
45.2 |
(29.3-69.9) |
1.90 |
(<LOD-6.60) |
44.7 |
(26.5-70.9) |
556 |
(377-1140) |
182 |
Males |
Total, 6 years and older |
78.3 |
(56.9-108) |
8.98 |
(<LOD-14.2) |
90.4 |
(65.6-122) |
632 |
(489-1040) |
627 |
6–11 years |
142 |
(104-194) |
16.4 |
(11.3-24.2) |
161 |
(94.9-244) |
1360 |
(597-1850) |
127 |
12–19 years |
123 |
(101-150) |
14.9 |
(10.5-21.1) |
142 |
(104-183) |
1030 |
(650-1320) |
211 |
20–39 years |
74.4 |
(45.4-122) |
8.45† |
(<LOD-15.0) |
86.4 |
(42.6-198) |
582† |
(305-1340) |
91 |
40–59 years |
52.3 |
(29.5-92.9) |
5.80† |
(<LOD-16.4) |
65.5 |
(31.2-117) |
358† |
(233-594) |
109 |
60 years and older |
55.7 |
(28.3-110) |
< LOD† |
|
58.1 |
(31.0-104) |
519† |
(377-1960) |
89 |
Females |
Total, 6 years and older |
74.2 |
(61.5-89.6) |
7.70 |
(3.61-11.3) |
85.9 |
(66.6-103) |
611 |
(473-856) |
661 |
6–11 years |
100 |
(70.3-144) |
10.0 |
(<LOD-26.2) |
107 |
(79.6-152) |
1130 |
(467-2300) |
122 |
12–19 years |
115 |
(88.3-151) |
15.2 |
(6.80-24.8) |
106 |
(85.2-129) |
805 |
(545-1840) |
239 |
20–39 years |
80.4 |
(57.7-112) |
9.50† |
(2.80-14.3) |
98.0 |
(58.7-155) |
465† |
(331-1400) |
106 |
40–59 years |
64.8 |
(44.8-93.5) |
5.70† |
(<LOD-13.6) |
68.8 |
(37.7-101) |
541† |
(393-1170) |
101 |
60 years and older |
39.4 |
(23.9-64.8) |
2.30† |
(<LOD-5.45) |
33.9 |
(21.6-61.6) |
560† |
(267-1140) |
93 |
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD.
† Estimate is subject to greater uncertainty due to small cell size. |
Table 5.2.d. Urinary daidzein: Non-Hispanic whites
Geometric mean and selected percentiles of urine concentrations (in µg/L) for non-Hispanic whites in the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 1999–2002. |
|
Geometric mean
(95% conf. interval) |
Selected percentiles (95% conf. interval) |
Sample
size |
|
10th |
50th |
90th |
Males and Females |
Total, 6 years and older |
58.4 |
(53.0-64.3) |
6.60 |
(5.33-8.10) |
56.2 |
(51.5-61.0) |
505 |
(439-636) |
2112 |
6–11 years |
83.8 |
(69.3-101) |
16.5 |
(13.0-20.3) |
76.6 |
(58.9-112) |
443 |
(385-694) |
196 |
12–19 years |
84.2 |
(62.7-113) |
9.60 |
(4.93-16.9) |
85.3 |
(68.3-119) |
755 |
(493-1310) |
375 |
20–39 years |
62.0 |
(52.1-73.8) |
6.59 |
(4.00-9.20) |
52.1 |
(44.3-65.5) |
601 |
(437-987) |
529 |
40–59 years |
54.7 |
(44.4-67.5) |
5.70 |
(3.16-8.00) |
54.8 |
(44.8-62.3) |
508 |
(393-852) |
434 |
60 years and older |
41.5 |
(35.3-48.9) |
5.00 |
(2.00-7.70) |
41.7 |
(36.9-50.6) |
337 |
(235-416) |
578 |
Males |
Total, 6 years and older |
63.4 |
(55.9-71.9) |
7.77 |
(5.80-10.1) |
59.0 |
(53.2-69.8) |
505 |
(418-667) |
1038 |
6–11 years |
86.4 |
(62.7-119) |
20.2† |
(13.0-26.6) |
77.7 |
(43.8-155) |
470† |
(317-694) |
101 |
12–19 years |
79.2 |
(50.9-123) |
11.1 |
(3.70-19.2) |
76.9 |
(53.0-121) |
586 |
(354-1300) |
190 |
20–39 years |
59.7 |
(48.0-74.3) |
5.30 |
(2.00-12.0) |
48.9 |
(37.3-66.9) |
663 |
(362-1410) |
231 |
40–59 years |
62.4 |
(50.6-76.9) |
6.30 |
(5.20-10.1) |
58.4 |
(49.8-71.1) |
501 |
(322-838) |
225 |
60 years and older |
53.1 |
(42.5-66.3) |
5.20 |
(2.90-10.0) |
57.2 |
(42.3-78.2) |
377 |
(273-570) |
291 |
Females |
Total, 6 years and older |
54.0 |
(48.2-60.4) |
6.20 |
(3.63-7.77) |
52.0 |
(44.8-59.2) |
505 |
(432-705) |
1074 |
6–11 years |
81.0 |
(59.0-111) |
13.7† |
(11.6-22.0) |
76.6 |
(58.9-121) |
466† |
(284-1130) |
95 |
12–19 years |
90.3 |
(67.4-121) |
9.30 |
(3.80-18.9) |
90.5 |
(68.3-140) |
922 |
(566-1410) |
185 |
20–39 years |
64.3 |
(49.0-84.4) |
6.70 |
(3.63-9.30) |
56.2 |
(43.1-79.2) |
530 |
(369-1300) |
298 |
40–59 years |
48.1 |
(35.4-65.4) |
3.16 |
(<LOD-10.1) |
45.0 |
(35.4-64.2) |
638 |
(220-1370) |
209 |
60 years and older |
34.3 |
(27.8-42.3) |
3.60 |
(<LOD-7.08) |
34.6 |
(28.5-41.1) |
262 |
(190-398) |
287 |
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD.
† Estimate is subject to greater uncertainty due to small cell size. |
Urinary daidzein (creatinine corrected)
Table 5.2.e. Urinary daidzein: Total population (creatinine corrected)
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for the total U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 1999–2002. |
|
Geometric mean
(95% conf. interval) |
Selected percentiles (95% conf. interval) |
Sample
size |
|
10th |
50th |
90th |
Males and Females |
Total, 6 years and older |
56.9 |
(51.4-63.0) |
6.67 |
(5.54-8.00) |
56.3 |
(50.0-64.0) |
536 |
(460-600) |
5347 |
6–11 years |
95.6 |
(83.2-110) |
18.4 |
(14.3-21.2) |
88.9 |
(73.4-112) |
635 |
(494-733) |
726 |
12–19 years |
64.8 |
(52.3-80.3) |
8.03 |
(5.73-10.4) |
63.4 |
(50.0-86.2) |
600 |
(402-797) |
1497 |
20–39 years |
51.1 |
(44.8-58.3) |
5.91 |
(4.85-7.32) |
48.8 |
(41.2-57.7) |
523 |
(390-624) |
1138 |
40–59 years |
52.6 |
(43.7-63.2) |
5.54 |
(3.58-7.49) |
51.0 |
(43.3-65.4) |
535 |
(391-689) |
951 |
60 years and older |
53.7 |
(46.4-62.1) |
6.01 |
(3.90-8.62) |
55.5 |
(43.5-71.3) |
389 |
(308-555) |
1035 |
Males |
Total, 6 years and older |
52.1 |
(45.8-59.3) |
5.96 |
(5.05-7.39) |
51.0 |
(45.2-59.7) |
497 |
(373-601) |
2595 |
6–11 years |
101 |
(80.4-127) |
22.7 |
(14.5-30.1) |
88.8 |
(58.6-143) |
553 |
(447-733) |
368 |
12–19 years |
62.0 |
(47.2-81.5) |
9.03 |
(6.10-10.4) |
61.6 |
(48.6-85.6) |
547 |
(301-921) |
735 |
20–39 years |
44.8 |
(36.8-54.7) |
5.36 |
(3.66-7.20) |
41.2 |
(33.1-47.9) |
497 |
(268-847) |
499 |
40–59 years |
45.5 |
(35.9-57.6) |
5.05 |
(3.28-7.38) |
45.2 |
(32.0-65.0) |
478 |
(263-693) |
480 |
60 years and older |
50.9 |
(41.8-62.0) |
4.52 |
(3.09-7.91) |
61.8 |
(44.2-81.0) |
363 |
(255-659) |
513 |
Females |
Total, 6 years and older |
61.9 |
(55.4-69.1) |
7.18 |
(5.91-9.10) |
61.0 |
(53.3-70.4) |
564 |
(468-628) |
2752 |
6–11 years |
90.3 |
(72.6-112) |
14.9 |
(11.9-19.0) |
86.3 |
(70.8-112) |
668 |
(414-838) |
358 |
12–19 years |
67.9 |
(54.6-84.3) |
6.80 |
(5.25-9.92) |
65.1 |
(48.1-91.9) |
628 |
(478-742) |
762 |
20–39 years |
58.1 |
(47.6-70.9) |
6.74 |
(3.67-9.55) |
56.2 |
(45.0-78.2) |
571 |
(370-783) |
639 |
40–59 years |
60.3 |
(48.0-75.8) |
6.58 |
(3.42-9.23) |
62.4 |
(43.2-75.6) |
564 |
(387-950) |
471 |
60 years and older |
56.0 |
(47.2-66.3) |
6.52 |
(4.52-11.4) |
50.9 |
(39.3-64.8) |
451 |
(312-560) |
522 |
Table 5.2.f. Urinary daidzein: Mexican Americans (creatinine corrected)
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for Mexican Americans in the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 1999–2002. |
|
Geometric mean
(95% conf. interval) |
Selected percentiles (95% conf. interval) |
Sample
size |
|
10th |
50th |
90th |
Males and Females |
Total, 6 years and older |
52.0 |
(43.7-61.9) |
4.81 |
(3.32-7.03) |
48.7 |
(38.2-65.0) |
546 |
(460-645) |
1495 |
6–11 years |
105 |
(81.0-136) |
11.9 |
(8.98-17.4) |
91.1 |
(65.5-149) |
957 |
(715-1660) |
225 |
12–19 years |
56.5 |
(47.8-66.8) |
7.20 |
(5.28-9.29) |
58.1 |
(45.6-71.6) |
511 |
(358-684) |
543 |
20–39 years |
43.0 |
(31.3-59.0) |
3.88 |
(<LOD-6.82) |
35.3 |
(23.2-57.9) |
486 |
(307-608) |
299 |
40–59 years |
46.9 |
(35.3-62.4) |
3.22 |
(<LOD-6.50) |
47.5 |
(36.0-67.3) |
483 |
(303-708) |
221 |
60 years and older |
40.3 |
(28.2-57.8) |
3.97 |
(<LOD-8.56) |
41.0 |
(27.1-73.4) |
343 |
(223-638) |
207 |
Males |
Total, 6 years and older |
51.8 |
(39.5-68.0) |
4.77 |
(2.90-7.95) |
51.0 |
(38.2-72.0) |
585 |
(471-708) |
723 |
6–11 years |
110 |
(79.0-152) |
14.8 |
(10.2-24.5) |
91.1 |
(57.4-149) |
957 |
(596-1140) |
117 |
12–19 years |
56.4 |
(43.0-73.9) |
5.65 |
(3.59-9.03) |
64.9 |
(39.8-90.0) |
614 |
(358-837) |
276 |
20–39 years |
45.8 |
(28.9-72.6) |
3.90 |
(<LOD-7.95) |
40.6 |
(21.8-91.4) |
495 |
(307-641) |
126 |
40–59 years |
44.2 |
(27.9-69.9) |
3.31† |
(<LOD-9.43) |
45.9 |
(32.2-68.7) |
542† |
(198-1020) |
105 |
60 years and older |
27.4 |
(15.6-48.1) |
< LOD† |
|
35.5 |
(15.0-63.9) |
201† |
(141-458) |
99 |
Females |
Total, 6 years and older |
52.2 |
(44.0-62.0) |
4.81 |
(3.00-8.02) |
43.5 |
(34.1-65.5) |
495 |
(384-600) |
772 |
6–11 years |
100 |
(70.6-142) |
8.61† |
(<LOD-15.7) |
103 |
(55.2-201) |
1080† |
(649-2300) |
108 |
12–19 years |
56.6 |
(47.1-68.0) |
8.23 |
(5.38-9.99) |
51.2 |
(36.9-65.0) |
399 |
(266-684) |
267 |
20–39 years |
39.9 |
(27.9-57.0) |
3.50 |
(<LOD-10.4) |
30.6 |
(22.1-66.4) |
384 |
(271-517) |
173 |
40–59 years |
50.1 |
(36.0-69.6) |
< LOD |
|
49.8 |
(27.9-102) |
474 |
(245-708) |
116 |
60 years and older |
55.6 |
(35.9-86.1) |
8.02† |
(<LOD-12.3) |
54.0 |
(28.9-89.9) |
479† |
(258-984) |
108 |
< LOD means less than the limit of detection for the uncorrected urine value, which may vary for some compounds by year. See Appendix D for LOD.
† Estimate is subject to greater uncertainty due to small cell size. |
Table 5.2.g. Urinary daidzein: Non-Hispanic blacks (creatinine corrected)
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for non-Hispanic blacks in the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 1999–2002. |
|
Geometric mean
(95% conf. interval) |
Selected percentiles (95% conf. interval) |
Sample
size |
|
10th |
50th |
90th |
Males and Females |
Total, 6 years and older |
51.3 |
(42.1-62.4) |
5.54 |
(3.95-7.05) |
57.1 |
(46.5-70.5) |
447 |
(306-599) |
1288 |
6–11 years |
113 |
(91.3-139) |
15.4 |
(10.2-21.8) |
109 |
(83.6-145) |
955 |
(683-1280) |
249 |
12–19 years |
67.0 |
(56.1-80.1) |
9.23 |
(6.59-10.9) |
75.7 |
(54.8-93.7) |
561 |
(317-975) |
450 |
20–39 years |
44.2 |
(32.2-60.8) |
5.07 |
(2.92-7.58) |
52.1 |
(38.4-71.7) |
348 |
(207-541) |
197 |
40–59 years |
39.6 |
(28.3-55.4) |
3.95 |
(<LOD-7.27) |
46.5 |
(26.5-64.1) |
272 |
(215-446) |
210 |
60 years and older |
42.5 |
(29.7-60.7) |
2.34 |
(<LOD-8.65) |
40.4 |
(27.2-79.3) |
488 |
(249-721) |
182 |
Males |
Total, 6 years and older |
47.3 |
(34.8-64.3) |
5.07 |
(<LOD-8.50) |
54.1 |
(40.2-70.2) |
472 |
(297-600) |
627 |
6–11 years |
132 |
(96.4-180) |
17.7 |
(9.66-30.8) |
151 |
(80.0-229) |
1050 |
(661-1300) |
127 |
12–19 years |
67.3 |
(55.8-81.2) |
9.03 |
(4.93-11.3) |
80.8 |
(61.6-106) |
499 |
(370-650) |
211 |
20–39 years |
36.1 |
(22.5-57.7) |
5.17† |
(<LOD-8.50) |
41.2 |
(24.5-70.2) |
249† |
(162-541) |
91 |
40–59 years |
31.9 |
(18.4-55.2) |
1.76† |
(<LOD-10.2) |
38.4 |
(20.4-64.8) |
258† |
(117-696) |
109 |
60 years and older |
41.4 |
(22.1-77.7) |
< LOD† |
|
36.0 |
(23.1-92.3) |
562† |
(214-1370) |
89 |
Females |
Total, 6 years and older |
54.9 |
(46.3-65.0) |
6.20 |
(3.75-8.65) |
62.2 |
(48.7-77.1) |
430 |
(302-639) |
661 |
6–11 years |
95.0 |
(71.7-126) |
11.9 |
(<LOD-20.6) |
86.3 |
(69.7-129) |
773 |
(381-1640) |
122 |
12–19 years |
66.7 |
(51.9-85.8) |
9.35 |
(5.68-12.5) |
72.7 |
(42.1-91.2) |
622 |
(251-1160) |
239 |
20–39 years |
51.9 |
(37.2-72.6) |
4.86† |
(2.92-7.58) |
64.6 |
(47.0-92.1) |
372† |
(207-639) |
106 |
40–59 years |
47.6 |
(35.3-64.2) |
6.58† |
(<LOD-11.1) |
48.4 |
(29.1-70.8) |
302† |
(215-802) |
101 |
60 years and older |
43.2 |
(28.0-66.6) |
2.31† |
(<LOD-10.0) |
44.0 |
(24.3-85.9) |
463† |
(248-828) |
93 |
< LOD means less than the limit of detection for the uncorrected urine value, which may vary for some compounds by year. See Appendix D for LOD.
† Estimate is subject to greater uncertainty due to small cell size. |
Table 5.2.h. Urinary daidzein: Non-Hispanic whites (creatinine corrected)
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for non-Hispanic whites in the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 1999–2002. |
|
Geometric mean
(95% conf. interval) |
Selected percentiles (95% conf. interval) |
Sample
size |
|
10th |
50th |
90th |
Males and Females |
Total, 6 years and older |
58.1 |
(52.9-64.0) |
6.90 |
(5.66-9.03) |
57.8 |
(51.0-64.2) |
506 |
(413-601) |
2112 |
6–11 years |
90.9 |
(75.0-110) |
19.0 |
(14.3-25.4) |
88.3 |
(70.8-112) |
494 |
(324-710) |
196 |
12–19 years |
63.8 |
(46.5-87.6) |
7.18 |
(4.27-12.2) |
63.6 |
(44.8-96.2) |
601 |
(386-987) |
375 |
20–39 years |
54.0 |
(47.0-62.1) |
6.52 |
(4.85-8.83) |
49.8 |
(39.7-60.4) |
579 |
(384-847) |
529 |
40–59 years |
57.4 |
(47.5-69.3) |
6.54 |
(4.23-9.94) |
59.0 |
(44.1-70.2) |
548 |
(377-807) |
434 |
60 years and older |
51.8 |
(44.0-61.0) |
6.01 |
(3.86-8.87) |
53.4 |
(41.3-69.6) |
318 |
(260-475) |
578 |
Males |
Total, 6 years and older |
53.7 |
(47.4-60.7) |
6.62 |
(5.39-8.80) |
54.1 |
(45.5-63.3) |
464 |
(336-586) |
1038 |
6–11 years |
95.0 |
(70.0-129) |
24.9† |
(14.1-31.9) |
88.3 |
(56.2-152) |
425† |
(302-710) |
101 |
12–19 years |
60.2 |
(39.6-91.4) |
9.03 |
(4.43-12.7) |
58.5 |
(41.9-92.6) |
463 |
(217-1030) |
190 |
20–39 years |
45.4 |
(36.2-56.9) |
5.50 |
(2.82-8.07) |
40.4 |
(29.1-54.6) |
497 |
(248-850) |
231 |
40–59 years |
52.5 |
(43.0-64.0) |
6.03 |
(4.60-9.94) |
47.0 |
(34.5-71.5) |
502 |
(276-723) |
225 |
60 years and older |
50.7 |
(40.7-63.3) |
5.14 |
(3.40-8.87) |
61.7 |
(45.4-80.0) |
313 |
(215-555) |
291 |
Females |
Total, 6 years and older |
62.8 |
(55.9-70.5) |
7.48 |
(5.49-10.5) |
60.8 |
(52.8-70.4) |
564 |
(423-655) |
1074 |
6–11 years |
86.6 |
(62.6-120) |
16.5† |
(11.1-21.2) |
86.6 |
(55.2-113) |
655† |
(275-938) |
95 |
12–19 years |
68.2 |
(48.9-95.0) |
6.56 |
(4.27-9.12) |
73.4 |
(45.1-113) |
628 |
(442-990) |
185 |
20–39 years |
64.0 |
(51.1-80.2) |
8.28 |
(2.74-14.0) |
58.0 |
(44.1-88.7) |
607 |
(384-852) |
298 |
40–59 years |
62.7 |
(46.3-84.9) |
6.79 |
(<LOD-12.6) |
65.4 |
(41.0-79.9) |
564 |
(356-1220) |
209 |
60 years and older |
52.6 |
(42.5-65.1) |
6.27 |
(<LOD-11.3) |
49.2 |
(35.1-66.1) |
316 |
(250-555) |
287 |
< LOD means less than the limit of detection for the uncorrected urine value, which may vary for some compounds by year. See Appendix D for LOD.
† Estimate is subject to greater uncertainty due to small cell size. |